Trials / Completed
CompletedNCT03769207
Evaluation of the Use of Apple Watch Features for Identification of Cardiac Arrhythmias
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- Apple Inc. · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Accepted
Summary
This post-marketing study is conducted to characterize the ability of Apple Watch rhythm analysis software to identify Atrial Fibrillation (AF) and facilitate subsequent clinical evaluation among users who contact AppleCare.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Ambulatory ECG | Eligible participants are asked to wear the ambulatory ECG monitor |
Timeline
- Start date
- 2018-12-08
- Primary completion
- 2019-07-05
- Completion
- 2019-08-20
- First posted
- 2018-12-07
- Last updated
- 2020-10-20
- Results posted
- 2020-10-20
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03769207. Inclusion in this directory is not an endorsement.